Brown Brothers Harriman & Co’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $56.1M | Buy |
141,046
+25,570
| +22% | +$11.2M | 0.25% | 81 |
|
|
2026
Q1 | $53.2M | Buy |
115,476
+109,924
| +1,980% | +$55.6M | 0.29% | 74 |
|
|
2025
Q4 | $3.14M | Buy |
5,552
+1,517
| +38% | +$808K | 0.02% | 218 |
|
|
2025
Q3 | $1.8M | Buy |
4,035
+160
| +4% | +$76.8K | 0.01% | 266 |
|
|
2025
Q2 | $2.11M | Buy |
3,875
+509
| +15% | +$266K | 0.01% | 244 |
|
|
2025
Q1 | $1.67M | Sell |
3,366
-7
| -0.2% | -$3.87K | 0.01% | 243 |
|
|
2024
Q4 | $1.76M | Buy |
3,373
+714
| +27% | +$372K | 0.01% | 238 |
|
|
2024
Q3 | $1.31M | Buy |
2,659
+431
| +19% | +$201K | 0.01% | 254 |
|
|
2024
Q2 | $991K | Buy |
2,228
+695
| +45% | +$277K | 0.01% | 274 |
|
|
2024
Q1 | $612K | Buy |
1,533
+722
| +89% | +$273K | ﹤0.01% | 337 |
|
|
2023
Q4 | $274K | Sell |
811
-186
| -19% | -$55.4K | ﹤0.01% | 446 |
|
|
2023
Q3 | $291K | Buy |
997
+644
| +182% | +$201K | ﹤0.01% | 424 |
|
|
2023
Q2 | $121K | Sell |
353
-81
| -19% | -$24.5K | ﹤0.01% | 556 |
|
|
2023
Q1 | $111K | Buy |
434
+118
| +37% | +$29.1K | ﹤0.01% | 588 |
|
|
2022
Q4 | $83.9K | Sell |
316
-100
| -24% | -$24.4K | ﹤0.01% | 624 |
|
|
2022
Q3 | $78K | Buy |
416
+167
| +67% | +$35.9K | ﹤0.01% | 646 |
|
|
2022
Q2 | $50K | Sell |
249
-157
| -39% | -$36.8K | ﹤0.01% | 706 |
|
|
2022
Q1 | $122K | Buy |
406
+346
| +577% | +$101K | ﹤0.01% | 599 |
|
|
2021
Q4 | $22K | Sell |
60
-18
| -23% | -$6.19K | ﹤0.01% | 818 |
|
|
2021
Q3 | $26K | Hold |
78
| – | – | ﹤0.01% | 777 |
|
|
2021
Q2 | $24K | Sell |
78
-36
| -32% | -$10.1K | ﹤0.01% | 785 |
|
|
2021
Q1 | $28K | Sell |
114
-15
| -12% | -$3.77K | ﹤0.01% | 734 |
|
|
2020
Q4 | $35K | Buy |
129
+33
| +34% | +$8.19K | ﹤0.01% | 712 |
|
|
2020
Q3 | $23K | Hold |
96
| – | – | ﹤0.01% | 677 |
|
|
2020
Q2 | $18K | Buy |
96
+39
| +68% | +$6.99K | ﹤0.01% | 700 |
|
|
2020
Q1 | $9K | Sell |
57
-48
| -46% | -$8.79K | ﹤0.01% | 705 |
|
|
2019
Q4 | $21K | Sell |
105
-312
| -75% | -$58.4K | ﹤0.01% | 791 |
|
|
2019
Q3 | $75K | Buy |
417
+102
| +32% | +$17.6K | ﹤0.01% | 581 |
|
|
2019
Q2 | $55K | Buy |
315
+306
| +3,400% | +$52.4K | ﹤0.01% | 574 |
|
|
2019
Q1 | $2K | Sell |
9
-2,205
| -100% | -$392K | ﹤0.01% | 954 |
|
|
2018
Q4 | $353K | Hold |
2,214
| – | – | ﹤0.01% | 277 |
|
|
2018
Q3 | $424K | Sell |
2,214
-72
| -3% | -$12.8K | ﹤0.01% | 266 |
|
|
2018
Q2 | $365K | Hold |
2,286
| – | – | ﹤0.01% | 262 |
|
|
2018
Q1 | $315K | Sell |
2,286
-138
| -6% | -$19.3K | ﹤0.01% | 286 |
|
|
2017
Q4 | $295K | Buy |
2,424
+129
| +6% | +$16.1K | ﹤0.01% | 297 |
|
|
2017
Q3 | $267K | Hold |
2,295
| – | – | ﹤0.01% | 289 |
|
|
2017
Q2 | $239K | Hold |
2,295
| – | – | ﹤0.01% | 302 |
|
|
2017
Q1 | $195K | Buy |
+2,295
| New | +$181K | ﹤0.01% | 334 |
|
|
2013
Q4 | – | Sell |
-1,800
| Closed | -$75K | – | 681 |
|
|
2013
Q3 | $75K | Sell |
1,800
-45,252
| -96% | -$2M | ﹤0.01% | 424 |
|
|
2013
Q2 | $2.65M | Buy |
+47,052
| New | +$2.59M | 0.01% | 149 |
|
Other funds holding ISRG
Brown Brothers Harriman & Co's ISRG Position: Q2 2026 in Review
Brown Brothers Harriman & Co increased its Intuitive Surgical (ISRG) stake by 22% in Q2 2026, buying an estimated $11.2M and bringing the position to 141,046 shares worth $56.1M. The position accounts for 0.25% of the portfolio, ranked #81.
Brown Brothers Harriman & Co first reported a position in ISRG in Q2 2013 and has held it in 40 quarters since. 2,244 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- Brown Brothers Harriman & Co held 141,046 shares of Intuitive Surgical worth $56.1M as of Q2 2026.
- Brown Brothers Harriman & Co bought 25,570 Intuitive Surgical shares in Q2 2026, an estimated $11.2M.
- Intuitive Surgical made up 0.25% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #81 holding.
- Brown Brothers Harriman & Co first reported a position in Intuitive Surgical in Q2 2013 and has held it in 40 quarters since.
- 2,244 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.